Logo image of LLAP

TERRAN ORBITAL CORP (LLAP) Stock Fundamental Analysis

NYSE:LLAP - New York Stock Exchange, Inc. - US88105P1030 - Common Stock - Currency: USD

0.25  +0 (+0.36%)

After market: 0.2511 +0 (+0.44%)

Fundamental Rating

2

Overall LLAP gets a fundamental rating of 2 out of 10. We evaluated LLAP against 66 industry peers in the Aerospace & Defense industry. LLAP may be in some trouble as it scores bad on both profitability and health. LLAP is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

LLAP had negative earnings in the past year.
In the past year LLAP has reported a negative cash flow from operations.
LLAP Yearly Net Income VS EBIT VS OCF VS FCFLLAP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

LLAP's Return On Assets of -83.62% is on the low side compared to the rest of the industry. LLAP is outperformed by 89.39% of its industry peers.
Industry RankSector Rank
ROA -83.62%
ROE N/A
ROIC N/A
ROA(3y)-87.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LLAP Yearly ROA, ROE, ROICLLAP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100

1.3 Margins

Looking at the Gross Margin, with a value of 4.37%, LLAP is doing worse than 80.30% of the companies in the same industry.
LLAP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LLAP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-41.97%
GM growth 5YN/A
LLAP Yearly Profit, Operating, Gross MarginsLLAP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

LLAP does not have a ROIC to compare to the WACC, probably because it is not profitable.
LLAP has more shares outstanding than it did 1 year ago.
The debt/assets ratio for LLAP is higher compared to a year ago.
LLAP Yearly Shares OutstandingLLAP Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M
LLAP Yearly Total Debt VS Total AssetsLLAP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -6.11, we must say that LLAP is in the distress zone and has some risk of bankruptcy.
LLAP has a worse Altman-Z score (-6.11) than 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.11
ROIC/WACCN/A
WACC6.76%
LLAP Yearly LT Debt VS Equity VS FCFLLAP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M

2.3 Liquidity

LLAP has a Current Ratio of 0.59. This is a bad value and indicates that LLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.59, LLAP is doing worse than 92.42% of the companies in the same industry.
LLAP has a Quick Ratio of 0.59. This is a bad value and indicates that LLAP is not financially healthy enough and could expect problems in meeting its short term obligations.
LLAP has a Quick ratio of 0.41. This is amonst the worse of the industry: LLAP underperforms 92.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.41
LLAP Yearly Current Assets VS Current LiabilitesLLAP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M

More info and screens

7

3. Growth

3.1 Past

LLAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.20%, which is quite good.
LLAP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.76%.
The Revenue has been growing by 76.12% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.56%
Revenue 1Y (TTM)10.76%
Revenue growth 3Y76.12%
Revenue growth 5YN/A
Sales Q2Q%-5.72%

3.2 Future

LLAP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.54% yearly.
LLAP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 97.32% yearly.
EPS Next Y0.75%
EPS Next 2Y18.07%
EPS Next 3Y13.54%
EPS Next 5YN/A
Revenue Next Year5.69%
Revenue Next 2Y19.27%
Revenue Next 3Y97.32%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LLAP Yearly Revenue VS EstimatesLLAP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
LLAP Yearly EPS VS EstimatesLLAP Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LLAP. In the last year negative earnings were reported.
Also next year LLAP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LLAP Price Earnings VS Forward Price EarningsLLAP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LLAP Per share dataLLAP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

LLAP's earnings are expected to grow with 13.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.07%
EPS Next 3Y13.54%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LLAP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TERRAN ORBITAL CORP

NYSE:LLAP (10/29/2024, 8:22:28 PM)

After market: 0.2511 +0 (+0.44%)

0.25

+0 (+0.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-12 2024-08-12/bmo
Earnings (Next)11-12 2024-11-12/bmo
Inst Owners27.16%
Inst Owner Change0%
Ins Owners0.89%
Ins Owner Change0%
Market Cap51.22M
Analysts76.36
Price Target0.34 (36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.42%
Min EPS beat(2)-49.07%
Max EPS beat(2)10.24%
EPS beat(4)2
Avg EPS beat(4)-4.78%
Min EPS beat(4)-49.07%
Max EPS beat(4)24.1%
EPS beat(8)4
Avg EPS beat(8)-4.69%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-26.82%
Min Revenue beat(2)-41.15%
Max Revenue beat(2)-12.49%
Revenue beat(4)0
Avg Revenue beat(4)-18.82%
Min Revenue beat(4)-41.15%
Max Revenue beat(4)-5.59%
Revenue beat(8)2
Avg Revenue beat(8)-13.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-90.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.09%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-40.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-31.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.65
BVpS-1.17
TBVpS-1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -83.62%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.37%
FCFM N/A
ROA(3y)-87.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-41.97%
GM growth 5YN/A
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.28%
Cap/Sales 11.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.41
Altman-Z -6.11
F-Score3
WACC6.76%
ROIC/WACCN/A
Cap/Depr(3y)463.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)26.95%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.56%
EPS Next Y0.75%
EPS Next 2Y18.07%
EPS Next 3Y13.54%
EPS Next 5YN/A
Revenue 1Y (TTM)10.76%
Revenue growth 3Y76.12%
Revenue growth 5YN/A
Sales Q2Q%-5.72%
Revenue Next Year5.69%
Revenue Next 2Y19.27%
Revenue Next 3Y97.32%
Revenue Next 5YN/A
EBIT growth 1Y14.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.11%
EBIT Next 3Y53.52%
EBIT Next 5YN/A
FCF growth 1Y50.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.6%
OCF growth 3YN/A
OCF growth 5YN/A